Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Greene

Showing results (361-370 of 410) with videos related to

Pageof 41
Sort By:
Circulation|October 13, 2017
Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure ControlSrinivasan Beddhu, Glenn M Chertow, Alfred K Cheung, et al.
Archives of Internal Medicine|April 30, 2008
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African AmericansLawrence J Appel, Jackson T Wright, Tom Greene, et al.
JAMA|June 21, 2022
Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical TrialNassir F Marrouche, Oussama Wazni, Christopher McGann, et al.
Annals of Internal Medicine|September 5, 2017
Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized TrialSrinivasan Beddhu, Michael V Rocco, Robert Toto, et al.
Diabetes, Obesity & Metabolism|May 10, 2023
The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trialsAmy Kang, Brendan Smyth, Brendon L Neuen, et al.
American Journal of Hypertension|June 28, 2023
Estimated Population Health Benefits of Intensive Systolic Blood Pressure Treatment Among SPRINT-Eligible US AdultsCatherine G Derington, Adam P Bress, Ransmond O Berchie, et al.
Annals of Internal Medicine|July 1, 2024
Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for Advanced Chronic Kidney Disease : A Systematic Review and Retrospective Individual Participant-Level Meta-analysis of Clinical TrialsElaine Ku, Lesley A Inker, Hocine Tighiouart, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 20, 2020
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m<sup>2</sup>: Subgroup Analysis of the Randomized CREDENCE TrialGeorge Bakris, Megumi Oshima, Kenneth W Mahaffey, et al.
Contemporary Clinical Trials|December 2, 2015
Rationale and design of A Trial of Sertraline vs. Cognitive Behavioral Therapy for End-stage Renal Disease Patients with Depression (ASCEND)S Susan Hedayati, Divya M Daniel, Scott Cohen, et al.
Journal of the American Society of Nephrology : JASN|July 21, 2019
Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINTSrinivasan Beddhu, Jincheng Shen, Alfred K Cheung, et al.
Pageof 41

Showing results (361-370 of 410) with videos related to

Sort By:
Pageof 41
Circulation|October 13, 2017
Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure ControlSrinivasan Beddhu, Glenn M Chertow, Alfred K Cheung, et al.
Archives of Internal Medicine|April 30, 2008
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African AmericansLawrence J Appel, Jackson T Wright, Tom Greene, et al.
JAMA|June 21, 2022
Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical TrialNassir F Marrouche, Oussama Wazni, Christopher McGann, et al.
Annals of Internal Medicine|September 5, 2017
Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized TrialSrinivasan Beddhu, Michael V Rocco, Robert Toto, et al.
Diabetes, Obesity & Metabolism|May 10, 2023
The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trialsAmy Kang, Brendan Smyth, Brendon L Neuen, et al.
American Journal of Hypertension|June 28, 2023
Estimated Population Health Benefits of Intensive Systolic Blood Pressure Treatment Among SPRINT-Eligible US AdultsCatherine G Derington, Adam P Bress, Ransmond O Berchie, et al.
Annals of Internal Medicine|July 1, 2024
Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for Advanced Chronic Kidney Disease : A Systematic Review and Retrospective Individual Participant-Level Meta-analysis of Clinical TrialsElaine Ku, Lesley A Inker, Hocine Tighiouart, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 20, 2020
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m<sup>2</sup>: Subgroup Analysis of the Randomized CREDENCE TrialGeorge Bakris, Megumi Oshima, Kenneth W Mahaffey, et al.
Contemporary Clinical Trials|December 2, 2015
Rationale and design of A Trial of Sertraline vs. Cognitive Behavioral Therapy for End-stage Renal Disease Patients with Depression (ASCEND)S Susan Hedayati, Divya M Daniel, Scott Cohen, et al.
Journal of the American Society of Nephrology : JASN|July 21, 2019
Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINTSrinivasan Beddhu, Jincheng Shen, Alfred K Cheung, et al.
Pageof 41